long half-life and large variability [Regulatives / Guidelines]

posted by Achievwin – US, 2020-08-12 17:22 (2145 d 08:47 ago) – Posting: # 21864
Views: 4,313

Welcome to the home of funky and funny pharmacokinetics where "Garbage in Gospel out" is day of life.

1. allowing long washout periods have seen studies with 4 -5 months washout.
2. other choice we can imagine is Two stage adaptive study design and including ANCOA in place of ANOVA...

want to know what other experts think?

❝ In short:


Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
441 visitors (0 registered, 441 guests [including 85 identified bots]).
Forum time: 02:10 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5